Form 4: Avidity Biosciences CEO Exercises Options and Sells Shares
SEC Form 4 Filing
Avidity Biosciences' CEO, Sarah Boyce, exercised stock options and sold shares on June 4, 2024, according to a Form 4 filing with the SEC.
Summary
- On June 4, 2024, Sarah Boyce, the President and CEO of Avidity Biosciences, exercised stock options to acquire 28,000 shares of common stock at a price of $1.24 per share.
- Simultaneously, Boyce sold 28,000 shares of Avidity Biosciences' common stock at a weighted-average price of $27.4207 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 9, 2023.
- Following these transactions, Boyce directly owns 112,117 shares of Avidity Biosciences' common stock and holds options for 817,015 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects standard insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company's performance.
Industry Context
This filing reflects routine insider trading activity, which is common among executives who receive stock options as part of their compensation. The use of a 10b5-1 trading plan suggests that these transactions were pre-planned and not based on any material non-public information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 06/09/2023 | Date the Rule 10b5-1 trading plan was adopted. |
| 06/04/2024 | Date of the stock option exercise and sale of shares. |
| 06/05/2024 | Date of the Form 4 filing. |
| 12/17/2029 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.